Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 15086999
[patent_doc_number] => 20190338310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => GENE THERAPY FOR TREATING WILSON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/474958
[patent_app_country] => US
[patent_app_date] => 2017-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16474958
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/474958 | Gene therapy for treating Wilson's disease | Dec 28, 2017 | Issued |
Array
(
[id] => 15912829
[patent_doc_number] => 10653635
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Nanofiber scaffolds for biological structures
[patent_app_type] => utility
[patent_app_number] => 15/857737
[patent_app_country] => US
[patent_app_date] => 2017-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 5105
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15857737
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/857737 | Nanofiber scaffolds for biological structures | Dec 28, 2017 | Issued |
Array
(
[id] => 12838396
[patent_doc_number] => 20180171305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => USE OF PHOSPHOLIPID SCRAMBLASE INHIBITORS FOR MODULATING INFLAMMATORY IMMUNE RESPONSES
[patent_app_type] => utility
[patent_app_number] => 15/849069
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18535
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15849069
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/849069 | Use of phospholipid scramblase inhibitors for modulating inflammatory immune responses | Dec 19, 2017 | Issued |
Array
(
[id] => 12783931
[patent_doc_number] => 20180153146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => Double Knockout (GT/CMAH-KO) Pigs, Organs and Tissues
[patent_app_type] => utility
[patent_app_number] => 15/848870
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12737
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15848870
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/848870 | Double knockout (GT/CMAH-KO) pigs, organs and tissues | Dec 19, 2017 | Issued |
Array
(
[id] => 13618887
[patent_doc_number] => 20180360995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF COSMETIC PROTEINS AND PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 15/845911
[patent_app_country] => US
[patent_app_date] => 2017-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 180869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15845911
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/845911 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF COSMETIC PROTEINS AND PEPTIDES | Dec 17, 2017 | Abandoned |
Array
(
[id] => 12832303
[patent_doc_number] => 20180169273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => IMMUNOADSORPTION
[patent_app_type] => utility
[patent_app_number] => 15/843803
[patent_app_country] => US
[patent_app_date] => 2017-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14075
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15843803
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/843803 | Immunoadsorption | Dec 14, 2017 | Issued |
Array
(
[id] => 12656989
[patent_doc_number] => 20180110829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-26
[patent_title] => TAFA4 COMPOUNDS AND USES THEREOF FOR TREATING PAIN
[patent_app_type] => utility
[patent_app_number] => 15/841342
[patent_app_country] => US
[patent_app_date] => 2017-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16595
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15841342
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/841342 | TAFA4 COMPOUNDS AND USES THEREOF FOR TREATING PAIN | Dec 13, 2017 | Abandoned |
Array
(
[id] => 12702514
[patent_doc_number] => 20180126004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => TREATMENT FOR EXPOSURE TO NERVE AGENT
[patent_app_type] => utility
[patent_app_number] => 15/841707
[patent_app_country] => US
[patent_app_date] => 2017-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21146
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15841707
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/841707 | Treatment for exposure to nerve agent | Dec 13, 2017 | Issued |
Array
(
[id] => 14636981
[patent_doc_number] => 10363217
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-30
[patent_title] => Nano-liposome carrier composition containing hybrid of Cas9 protein and guide RNA
[patent_app_type] => utility
[patent_app_number] => 15/837987
[patent_app_country] => US
[patent_app_date] => 2017-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 25
[patent_no_of_words] => 8677
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15837987
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/837987 | Nano-liposome carrier composition containing hybrid of Cas9 protein and guide RNA | Dec 10, 2017 | Issued |
Array
(
[id] => 13339909
[patent_doc_number] => 20180221494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => SITE-SPECIFIC DELIVERY OF NUCLEIC ACIDS BY COMBINING TARGETING LIGANDS WITH ENDOSOMOLYTIC COMPONENTS
[patent_app_type] => utility
[patent_app_number] => 15/837785
[patent_app_country] => US
[patent_app_date] => 2017-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15837785
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/837785 | SITE-SPECIFIC DELIVERY OF NUCLEIC ACIDS BY COMBINING TARGETING LIGANDS WITH ENDOSOMOLYTIC COMPONENTS | Dec 10, 2017 | Abandoned |
Array
(
[id] => 12808621
[patent_doc_number] => 20180161377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => METHOD OF TREATING NEUROLOGICAL DISORDERS WITH STEM CELL THERAPY
[patent_app_type] => utility
[patent_app_number] => 15/836849
[patent_app_country] => US
[patent_app_date] => 2017-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6937
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15836849
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/836849 | METHOD OF TREATING NEUROLOGICAL DISORDERS WITH STEM CELL THERAPY | Dec 8, 2017 | Abandoned |
Array
(
[id] => 12624528
[patent_doc_number] => 20180100006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => METHOD FOR THE EXPRESSION OF POLYPEPTIDES USING MODIFIED NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 15/833012
[patent_app_country] => US
[patent_app_date] => 2017-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15833012
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/833012 | METHOD FOR THE EXPRESSION OF POLYPEPTIDES USING MODIFIED NUCLEIC ACIDS | Dec 5, 2017 | Pending |
Array
(
[id] => 15880515
[patent_doc_number] => 10646582
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-12
[patent_title] => Block copolymers
[patent_app_type] => utility
[patent_app_number] => 15/827793
[patent_app_country] => US
[patent_app_date] => 2017-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 20
[patent_no_of_words] => 52480
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 386
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15827793
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/827793 | Block copolymers | Nov 29, 2017 | Issued |
Array
(
[id] => 13504829
[patent_doc_number] => 20180303957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => NUCLEIC ACID-LIPOPOLYMER COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 15/822840
[patent_app_country] => US
[patent_app_date] => 2017-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15822840
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/822840 | NUCLEIC ACID-LIPOPOLYMER COMPOSITIONS | Nov 26, 2017 | Abandoned |
Array
(
[id] => 15579743
[patent_doc_number] => 10580262
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Eluting matrix and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/813917
[patent_app_country] => US
[patent_app_date] => 2017-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 31
[patent_no_of_words] => 14342
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15813917
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/813917 | Eluting matrix and uses thereof | Nov 14, 2017 | Issued |
Array
(
[id] => 16277081
[patent_doc_number] => 10760098
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-01
[patent_title] => Membrane-penetrating peptides to enhance transfection and compositions and methods for using same
[patent_app_type] => utility
[patent_app_number] => 15/811423
[patent_app_country] => US
[patent_app_date] => 2017-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 24
[patent_no_of_words] => 30738
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15811423
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/811423 | Membrane-penetrating peptides to enhance transfection and compositions and methods for using same | Nov 12, 2017 | Issued |
Array
(
[id] => 15631771
[patent_doc_number] => 10588853
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-17
[patent_title] => Methods for creating a transgenic cell with microbubbles
[patent_app_type] => utility
[patent_app_number] => 15/811066
[patent_app_country] => US
[patent_app_date] => 2017-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 33
[patent_no_of_words] => 21919
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15811066
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/811066 | Methods for creating a transgenic cell with microbubbles | Nov 12, 2017 | Issued |
Array
(
[id] => 15099717
[patent_doc_number] => 10471153
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-12
[patent_title] => Ice-based lipid nanoparticle formulation for delivery of mRNA
[patent_app_type] => utility
[patent_app_number] => 15/809605
[patent_app_country] => US
[patent_app_date] => 2017-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 36087
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15809605
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/809605 | Ice-based lipid nanoparticle formulation for delivery of mRNA | Nov 9, 2017 | Issued |
Array
(
[id] => 15946087
[patent_doc_number] => 10660922
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-26
[patent_title] => Cell-based therapy for the pulmonary system
[patent_app_type] => utility
[patent_app_number] => 15/806539
[patent_app_country] => US
[patent_app_date] => 2017-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 73
[patent_figures_cnt] => 127
[patent_no_of_words] => 27039
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15806539
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/806539 | Cell-based therapy for the pulmonary system | Nov 7, 2017 | Issued |
Array
(
[id] => 15493559
[patent_doc_number] => 20200046968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => Transdermal Optogenetic Peripheral Nerve Stimulation
[patent_app_type] => utility
[patent_app_number] => 16/344866
[patent_app_country] => US
[patent_app_date] => 2017-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16344866
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/344866 | Transdermal optogenetic peripheral nerve stimulation | Oct 30, 2017 | Issued |